Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130194 · ClinicalTrials.gov registry record · Phase 2
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
A Phase 2 study, sponsored by St. Louis University.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT01130194 is a Phase 2 study that has completed, run by St. Louis University. The registered enrollment target is 29 participants.
The verdict
NCT01130194, a Phase 2 study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
Follicular lymphoma has historically been considered an incurable lymphoma. By combining multiple effective treatments, the investigators believe that prolonged disease-free survival is achievable in this disease. The investigators goal is to have at least 60-70% of our patients in first continuous complete remission 15 years from initiation of treatment.
Interventions
- OTHER Combination of treatment modalities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-07 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130194
The ClinicalTrials.gov registry entry for NCT01130194 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combination of treatment modalities is the first listed.
NCT01130194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01130194 about?
NCT01130194 is a clinical study titled "Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma". Follicular lymphoma has historically been considered an incurable lymphoma. By combining multiple effective treatments, the investigators believe that prolonged disease-free survival is achievable in this disease. The investigators goal is to have at least 60-70% of our patients in first continuous ...
What is the current status of trial NCT01130194?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2006-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01130194?
The interventions under investigation include: Combination of treatment modalities (OTHER).
Who is sponsoring clinical trial NCT01130194?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.